Cost-Effectiveness Analysis of Brief and Expanded Evidence-Based Risk Reduction Interventions for HIV-Infected People Who Inject Drugs in the United States

Open Access

Peer-reviewed

Research Article

Dahye L. Song ,

* E-mail: dsong@fas.harvard.edu

Affiliation PhD Program in Health Policy, Harvard University, Cambridge, Massachusetts, United States of America
⨯
Frederick L. Altice,

Affiliation AIDS Program, Section of Infectious Diseases, Yale University School of Medicine, New Haven, Connecticut, United States of America
⨯
Michael M. Copenhaver,

Affiliations Division of Epidemiology of Microbial Diseases, Yale University School of Public Health, New Haven, Connecticut, United States of America, Department of Allied Health Sciences, University of Connecticut, Storrs, Connecticut, United States of America
⨯
Elisa F. Long

Affiliation UCLA Anderson School of Management, Los Angeles, California, United States of America
⨯

Reader Comments (0)

HIV epidemiology
Is the Subject Area "HIV epidemiology" applicable to this article?

Thanks for your feedback.
HIV
Is the Subject Area "HIV" applicable to this article?

Thanks for your feedback.
Antiretroviral therapy
Is the Subject Area "Antiretroviral therapy" applicable to this article?

Thanks for your feedback.
AIDS
Is the Subject Area "AIDS" applicable to this article?

Thanks for your feedback.
HIV prevention
Is the Subject Area "HIV prevention" applicable to this article?

Thanks for your feedback.
HIV clinical manifestations
Is the Subject Area "HIV clinical manifestations" applicable to this article?

Thanks for your feedback.
Medical risk factors
Is the Subject Area "Medical risk factors" applicable to this article?

Thanks for your feedback.
Opioids
Is the Subject Area "Opioids" applicable to this article?

Thanks for your feedback.